Complement-Based Drug Development Summit leaderboard
  • Wednesday, October 14, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

17th World ADC San Diego Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Page 482

Nestlé to acquire Aimmune Therapeutics

Aug 31, 2020
Nestlé and Aimmune Therapeutics, Inc. a biopharmaceutical company developing and commercializing treatments for potentially life-threatening food allergies (Aimmune), have entered into…
Read More...

Seneca Therapeutics Licenses Tumor Endothelial Marker 8 (TEM8) to Enable Better Patient Selection…

Aug 31, 2020
Seneca Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to the development of oncolytic immune-therapeutics based on Seneca Valley Virus (SVV-001), announced the…
Read More...

Vor Biopharma and Metagenomi to Collaborate on Engineered Hematopoietic Stem-Cell Therapies

Aug 31, 2020
Vor Biopharma, an oncology company pioneering engineered hematopoietic stem cells (eHSCs) for the treatment of cancer, and Metagenomi, a gene editing company discovering breakthrough…
Read More...

Rocket Pharmaceuticals Receives FDA Fast Track Designation for RP-L401 Gene Therapy for Infantile…

Aug 27, 2020
Rocket Pharmaceuticals, Inc. a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, announces that the U.S. Food…
Read More...

Piramal to Collaborate with Epirium Bio on Exclusive Integrated Development & Manufacturing…

Aug 27, 2020
Piramal Pharma Solutions announced that the company will be partnering with Epirium Bio on an exclusive manufacturing relationship for new orphan drugs targeting rare diseases with high…
Read More...

BeiGene Announces Exclusive License Agreement for Neutralizing COVID-19 Antibodies Developed by…

Aug 27, 2020
BeiGene, Ltd. and Singlomics Biopharmaceuticals Co., Ltd., announced that the companies have executed an exclusive license agreement for BeiGene to develop, manufacture and…
Read More...

Akers Biosciences and Premas Biotech Announce SARS CoV-2 Positive Proof of Concept Results

Aug 27, 2020
Akers Biosciences, Inc. announced with its partner, Premas Biotech, positive proof of concept results from Animal Studies conducted during a 4 week test of its SARS-CoV-2 vaccine…
Read More...

European Commission signs first Covid-19 vaccine contract with AstraZeneca

Aug 27, 2020
Today, the first contract the European Commission has negotiated on behalf of the EU Member States with a pharmaceutical company entered into force following the formal signature…
Read More...

Ivy Brain Tumor Center and Vivace Therapeutics Collaborate to Test Targeted Agent in Glioblastoma…

Aug 26, 2020
Ivy Brain Tumor Center at Barrow Neurological Institute announced today a new collaboration with Vivace Therapeutics. The Ivy Brain Tumor Center, which employs a bold, early-phase…
Read More...

HiFiBiO Therapeutics Submits IND Application for Fully Human SARS-CoV-2 Neutralizing Antibody for…

Aug 26, 2020
HiFiBiO Therapeutics, a multinational biotherapeutics company focused on the development of novel antibodies for immunomodulation, announced the submission of an Investigational New…
Read More...
Previous 1 … 480 481 482 483 484 … 957 Next
2nd Non-Opioid Pain Therapeutics Summit
Muscular Disorders Drug Development Summit
Amylin-Based Therapeutics Summit
Microbiome Movement USA Summit 2026
Cell Therapy for Autoimmune Disease Summit
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Biomarker Operations & Biospecimen Management
2nd Obesity & Weight Loss Drug Development Summit Europe
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
10th IPF Summit
PFS & Injectable Drug Devices Europe
Ophthalmic Drug Delivery Summit
Obesity & Weight Loss Drug Development Summit West
17th World ADC London
ADC Payload Summit 2026
10th Antifibrotic Drug Development Summit 2026
Model-Informed Drug Development Summit 2026
IMPACCT Real-World Evidence Summit
Raw Materials for Cell & Gene Therapy Summit
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
17th World ADC San Diego
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Cognizant Extends Gilead Partnership to Expand AI-Enabled DevOps
  • CSL, Alentis Partner on $1.55B Kidney and Liver Drug
  • Alector Licenses Parkinson’s Drug Program to Genentech for $1.27B
  • KymaThera Raises $80M to Advance PI3Kα Cancer Drug
  • Industry Leaders Explore the Future of RNA Therapeutics Beyond Splicing

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Industry Leaders Explore the Future of RNA Therapeutics…

Direct RNA Binding Emerges as a Powerful Approach for…

AI, Structure Prediction and Advanced Computational Tools…

New Preclinical Data and Translational Advances Set to Take…

FDA, Health Canada & Leading Biopharma Organizations…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.